Search
Showing results for "mental health aboriginal"
As our Key Relationships Officer, you will be responsible for developing key relationships with donors in support of the Institute’s research mission.
Ten emerging researchers took to the stage for our fourth Illuminate PitchFest, where community support helped push the total raised for Illuminate Awards past $1 million.
In 2026, Rare Disease Day is recognised on 28 February to raise awareness and generate change for people living with rare disease, their families and carers worldwide. This year’s global theme, More than you can imagine, highlights the immense impact of rare disease on families across the world.
Researchers developing a world-first treatment that targets an underlying cause of asthma have secured a $499,640 grant from the Future Health, Research and Innovation Fund – Innovation Seed Fund.
Two infectious disease researchers from Papua New Guinea (PNG) dedicated to reducing rates of childhood mortality in their home country are making significant advances thanks to support from the Deborah Lehmann Research Award (DLRA).
Professor Andrew Whitehouse, the Angela Wright Bennett Professor of Autism Research and CliniKids Director, has been appointed Deputy Director (Research) at The Kids Research Institute Australia.
For the third year running, ten emerging researchers took to the stage to pitch their innovative research projects at our annual Illuminate PitchFest event, inspiring a room full of donors of their vision and commitment to drive improved health outcomes for kids.
An early childhood researcher based at The Kids Research Institute Australia’s Adelaide office has been honoured at South Australia’s Science Excellence and Innovation Awards for her work revealing the link between screen time exposure and toddlers’ language development.
A complex five-year experiment which cracked the code of a genetic mystery has paved the way for faster and more accurate diagnoses of the most rare and unknown diseases affecting children.
Researchers dedicated to developing the first cancer immunotherapy tablet have been boosted by a $374,000 CUREator top-up funding grant.